VBLT Vascular Biogenics Ltd Compare

yahoo

Data Presented at ECTRIMS 2018 Show Potential of MOSPD2 as a Novel Target for Treatment of CNS Inflammation, Such as Multiple Sclerosis

yahoo

Edited Transcript of VBLT earnings conference call or presentation 16-Aug-18 12:30pm GMT

yahoo

The Daily Biotech Pulse: No Anxiety For Biohaven, Strongbridge's About-Face, Bristol-Myers Squibb's FDA Wait

yahoo

Vascular Biogenics Reports Q2 Loss, Lags Revenue Estimates

yahoo

Vascular Biogenics: 2Q Earnings Snapshot

yahoo

Benzinga's Daily Biotech Pulse: Vascular Biogenics Soars On Positive Platform Data, Axovant Licenses Parkinson's Candidate

yahoo

Edited Transcript of VBLT earnings conference call or presentation 17-May-18 12:30pm GMT

yahoo

Vascular Biogenics Enters Oversold Territory

zacks

Implied Volatility Surging for Vascular Biogenics Stock Options

yahoo

VBL Therapeutics Awarded $2.5 Million Non-Dilutive Grant by the Israel Innovation Authority

yahoo

Edited Transcript of VBLT earnings conference call or presentation 15-Mar-18 12:30pm GMT

yahoo

VBL Therapeutics Announces Year End 2017 Financial Results

marketwatch

Vascular Biogenics' stock plummets after brain cancer treatment trial fails

yahoo

Does Vascular Biogenics Ltd’s CEO Pay Compared Well With Peers?

yahoo

Vascular Biogenics Ltd : Is Healthcare An Attractive Sector Play?

yahoo

What Falling Estimates & Price Mean for Vascular Biogenics

yahoo

Why Vascular Biogenics Ltd. Is Tanking Today

yahoo

Here’s Why Vascular Biogenics Ltd Stock Is Slumping Today

reuters

VBL Therapeutics prices 2.5 million ordinary share offering

yahoo

Edited Transcript of VBLT earnings conference call or presentation 14-Nov-17 1:30pm GMT

yahoo

Vascular Biogenics reports 3Q loss

reuters

VBL therapeutics Q3 loss per share $0.24

yahoo

Who Are The Major Shareholders Of Vascular Biogenics Ltd ?

reuters

VBL Therapeutics and Nanocarrier signs agreement for VB-111 in Japan

reuters

Nanocarrier signs exclusive agreement with VBL Therapeutics for VB-111 in Japan

seekingalpha

Vascular Biogenics Stock May Shoot Up On The Back Of Upcoming Catalysts

reuters

VBL THERAPEUTICS OPENS NEW GENE THERAPY MANUFACTURING PLANT, HEADQUARTERS